510(k) · Cleared

Cleared

Upstream GoBack Crossing Catheter

K182937510(k) TraditionalCleared May 23, 2019213-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Upstream Peripheral Technologies, Ltd. · DQY Catheter, Percutaneous

Cleared on May 23, 2019 as substantially equivalent to K001577 (Lumend, Inc., 2001) after a 213-day review. Its family tree reaches back 1 generation to 2001. 1 later device descends from it.

Decided: May 23, 2019
Review: 213 days
Class: Class II
Product code: DQY
Recalls: None
Predicates: 1

Its longest line of descent runs back 1 generation to K001577 (2001). 1 later device descends from it, 1 citing it directly.

By dateBy generation

Root · 1 generation backK001577 Outback CatheterLumend, Inc. · 2001 · Recalled
This deviceK182937 Upstream GoBack Crossing CatheterUpstream Peripheral Technologies, Ltd. · 2019
Descendant · cites it directly · 0 of its ownK211802 GoBack Crossing CatheterUpstream Peripheral Technologies, Ltd. · 2022

Most influential descendants

Showing 1 of 1 · See all

K211802GoBack Crossing CatheterUpstream Peripheral Technologies, Ltd. · 2022 · cites it directly0descendants

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K001577	Outback Catheter	Lumend, Inc.	2001	1
0 (this device)	K182937	Upstream GoBack Crossing Catheter	Upstream Peripheral Technologies, Ltd.	2019	—
+1	K211802	GoBack Crossing Catheter	Upstream Peripheral Technologies, Ltd.	2022	—

Descendants by year cleared

Year cleared	Devices	With a Class I recall
2022	1	0

FIG. 1 — Lineage of K182937, 2001–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

#1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K001577	Outback Catheter Summary page 4 …g Total Occlusions Classification: Class II per 21 CFR 870.1250 Product Code: PDU Predicate Device: Cordis Outback Catheter (K001577) Reference Device: ReFlow Wingman Crossing Catheter (K151880) Intended Use / Indications for Use The Upstream GoBa…	Lumend, Inc.	2001	1
†	K151880	Wingman Crossing Catheter	Reflow Medical	2015	—

Also cleared against K001577: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

Number	Device	Applicant	Decided	Descendants
K211802	GoBack Crossing Catheter	Upstream Peripheral Technologies, Ltd.	2022	0

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

Its one ancestor has a recall.
Of its descendants, K211802 (Upstream Peripheral Technologies, Ltd., 2022) has gone furthest, with 0 descendants of its own.
4 other devices also cite its predicate K001577.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · DQY

21in 2025

2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	16	85	6	313
2008	31	66	12	496
2009	37	73	17	819
2010	22	74	32	1,293
2011	36	71	6	1,211
2012	30	87	2	1,191
2013	32	92	36 (1)	1,352
2014	19	127	3	1,497
2015	27	118	3	2,337
2016	22	117	22 (7)	2,252
2017	26	113	8	2,489
2018	25	106	2	2,855
2019	30	111	1	2,902
2020	20	120	2	2,889
2021	18	81	2	3,006
2022	18	74	0	2,643
2023	18	114	17	3,049
2024	16	87	1	3,190
2025	21	115	1 (1)	3,056
2026	11	30	2 (1)	—

What is it indicated for?

The Upstream GoBack Crossing Catheter is intended to be used in conjunction with steerable guidewires to access discrete regions of the peripheral vasculature. It may be used to facilitate placement and exchange of guidewires.

The Upstream GoBack Crossing Catheter is not intended for use in the coronary, cerebral or carotid vasculature.

Indications for use as stated in the FDA summary.

https://510kreport.com/device/K182937 · printed Nov 6, 2026

Cite this page

510(k) Report. “K182937: Upstream GoBack Crossing Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K182937

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026